Acute SSRI Administration Affects the Processing of Social Cues in Healthy Volunteers

Enhancement of serotonin neurotransmission plays an important role in the antidepressant response to agents presently available to treat depression. This response forms the major evidence for the role of serotonin in affective and social behaviour in humans. The present study investigated the effects of acute administration of the selective serotonin reuptake inhibitor (SSR1), citalopram (10 mg, i.v.) upon a measure of emotional processing in healthy female volunteers. Subjects completed a facial expression recognition task following infusion of citalopram or saline (between-subjects design, double-blind). Facial expressions associated with five basic emotions—happiness, sadness, fearfulness, anger and disgust—were displayed. Each face had been ‘morphed’ between neutral (0%) and each emotional standard (100%) in 10% steps, leading to a range of emotional intensities. Mood and subjective experience were also monitored throughout the testing session. Volunteers receiving citalopram detected a higher number of facial expressions of fear and happiness, with reduced response times, relative to those given the placebo. By contrast, changes in the recognition of other basic emotions were not observed following citalopram. Notable differences in mood were also not apparent in these volunteers. These results suggest that acute administration of antidepressant drugs may affect neural processes involved in the processing of social information. This effect may represent an early acute effect of SSRIs on social and emotional processing that is relevant to their therapeutic actions.

[1]  F. Strian,et al.  Evaluation of depressive states, especially in longitudinal studies. , 1974, Modern problems of pharmacopsychiatry.

[2]  Michael J. Raleigh,et al.  Serotonergic mechanisms promote dominance acquisition in adult male vervet monkeys , 1991, Brain Research.

[3]  M. Raichle,et al.  A functional anatomical study of unipolar depression , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[4]  P. Ekman.  An argument for basic emotions , 1992 .

[5]  Masatoshi Tanaka,et al.  Psychological stress increases serotonin release in the rat amygdala and prefrontal cortex assessed by in vivo microdialysis , 1993, Neuroscience Letters.

[6]  Takeshi Inoue,et al.  Effect of conditioned fear stress on serotonin metabolism in the rat brain , 1993, Pharmacology Biochemistry and Behavior.

[7]  C. Montigny,et al.  Current advances and trends in the treatment of depression. , 1994, Trends in pharmacological sciences.

[8]  R. Adolphs,et al.  Impaired recognition of emotion in facial expressions following bilateral damage to the human amygdala , 1994, Nature.

[9]  R. Fuller,et al.  Serotonin uptake inhibitors: uses in clinical therapy and in laboratory research. , 1995, Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques.

[10]  D. Perrett,et al.  A differential neural response in the human amygdala to fearful and happy facial expressions , 1996, Nature.

[11]  F. Graeff,et al.  Role of 5-HT in stress, anxiety, and depression , 1996, Pharmacology Biochemistry and Behavior.

[12]  D. Perrett,et al.  A specific neural substrate for perceiving facial expressions of disgust , 1997, Nature.

[13]  D. Perrett,et al.  Facial expression megamix: Tests of dimensional and category accounts of emotion recognition , 1997, Cognition.

[14]  A. Young,et al.  Impaired recognition of disgust in Huntington's disease gene carriers. , 1997, Brain : a journal of neurology.

[15]  A. Young,et al.  Neural responses to facial and vocal expressions of fear and disgust , 1998, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[16]  J. Gorman,et al.  Clinical utility of the selective serotonin reuptake inhibitors in the spectrum of anxiety , 1998, Biological Psychiatry.

[17]  S. Maier,et al.  Escapable and inescapable stress differentially alter extracellular levels of 5-HT in the basolateral amygdala of the rat , 1998, Brain Research.

[18]  Brian Knutson,et al.  Selective alteration of personality and social behavior by serotonergic intervention. , 1998, The American journal of psychiatry.

[19]  R. Blair,et al.  Selective impairment in the recognition of anger induced by diazepam , 1999, Psychopharmacology.

[20]  A. Bouhuys,et al.  Depressed patients' perceptions of facial emotions in depressed and remitted states are associated with relapse: a longitudinal study. , 1999, The Journal of nervous and mental disease.

[21]  A. Young,et al.  Recognition of facial emotion in nine individuals with bilateral amygdala damage , 1999, Neuropsychologia.

[22]  S Z Rapcsak,et al.  Fear recognition deficits after focal brain damage: a cautionary note. , 2000, Neurology.

[23]  P. Broks,et al.  Face processing impairments after encephalitis: amygdala damage and recognition of fear , 2000 .

[24]  Lisa M Shin,et al.  Exaggerated amygdala response to masked facial stimuli in posttraumatic stress disorder: a functional MRI study , 2000, Biological Psychiatry.

[25]  A. Young,et al.  Impaired recognition and experience of disgust following brain injury , 2000, Nature Neuroscience.

[26]  D. Perrett,et al.  Administration of the beta-adrenoceptor blocker propranolol impairs the processing of facial expressions of sadness , 2001, Psychopharmacology.

[27]  Michael Davis,et al.  The amygdala: vigilance and emotion , 2001, Molecular Psychiatry.

[28]  P. Cowen,et al.  Low-dose citalopram as a 5-HT neuroendocrine probe , 2001, Psychopharmacology.

[29]  Stephen Maren.  Neurobiology of Pavlovian fear conditioning. , 2001, Annual review of neuroscience.

[30]  D. Zuroff,et al.  The Effect of Tryptophan on Social Interaction in Everyday Life: A Placebo-Controlled Study , 2001, Neuropsychopharmacology.

[31]  M. Mintun,et al.  Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: an fMRI study , 2001, Biological Psychiatry.

[32]  F. Graeff,et al.  Opposite effects of nefazodone in two human models of anxiety , 2001, Psychopharmacology.

[33]  R. Blair,et al.  A comparison of the effects of a β-adrenergic blocker and a benzodiazepine upon the recognition of human facial expressions , 2002, Psychopharmacology.

[34]  P. Cowen,et al.  Repeated administration of citalopram or reboxetine reduces the perception of negative emotions from facial expression. , 2002 .

[35]  J. Potvin,et al.  Fluoxetine: a review of receptor and functional effects and their clinical implications , 2005, Psychopharmacology.

[36]  J. Deakin,et al.  Effects of ritanserin on aversive classical conditioning in humans , 2005, Psychopharmacology.

[37]  G. Griebel,et al.  Acute and chronic treatment with 5-HT reuptake inhibitors differentially modulate emotional responses in anxiety models in rodents , 2005, Psychopharmacology.